Expect More.Creating a new paradigm for viral and liver diseases
One person without a cure is one person too many.
Call it blue-sky thinking, but we believe every patient deserves the chance of a cure. Our team of world-class infectious disease and liver disease experts are redefining today’s standards to reach new heights for patients globally.
About Bluejay Therapeutics
At Bluejay, we are discovering life-changing medicines and cures for people with viral and liver diseases, starting with chronic hepatitis B (CHB) and chronic hepatitis D (CHD).
Recent News, Posters, and Presentations
Bluejay is on a mission to illuminate a path toward curative treatments for serious viral and liver diseases.At Bluejay, we each embody a passion and connection to our purpose, and we are unified in envisioning a world where a functional cure is possible for everyone with CHB/CHD. We believe it’s a question of when, not if.
Our team combines decades of experience in HBV, virology, immunology and liver diseases with scientific integrity and a personal commitment to improve the lives of people living with these diseases.
We apply this knowledge to identify and develop highly differentiated assets that offer the greatest therapeutic potential with the lowest risk for patients.
Founder and CEO/Chairman
Hassan JavanbakhtChief Scientific Officer
Chief Medical Officer
Bluejay is passionate about shifting the treatment paradigms for patients with difficult viral and liver diseases.
We’re starting by making a functional cure for CHB a reality and developing a life-changing treatment for CHD – both have been in the shadow of other infectious diseases for too long.